PropertyValue
?:abstract
  • This paper provides empirical evidence on the impact of patents on drug prices across developing countries. It uses sales data on HIV/AIDS drugs in a sample of 34 low and middle-income countries between 1995 and mid-2000. The main findings are that patents do shift drug prices up, that drug prices are correlated to per capita income levels, and that drug firms follow a skimming strategy when pricing new HIV/AIDS drugs. That is, there is across country and intertemporal price discrimination in the global drug markets. (xsd:string)
?:contributor
?:dateModified
  • 2007 (xsd:gyear)
?:datePublished
  • 2007 (xsd:gyear)
?:doi
  • 10.1080/00036840500438954 ()
?:duplicate
?:hasFulltext
  • true (xsd:boolean)
is ?:hasPart of
?:inLanguage
  • en (xsd:string)
?:isPartOf
?:issueNumber
  • 4 (xsd:string)
?:linksDOI
?:linksURN
is ?:mainEntity of
?:name
  • Pricing and Patents of HIV/AIDS Drugs in Developing Countries (xsd:string)
?:provider
?:publicationType
  • Zeitschriftenartikel (xsd:string)
  • journal_article (en)
?:sourceInfo
  • GESIS-SSOAR (xsd:string)
  • In: Applied Economics, 39, 2007, 4, 505-518 (xsd:string)
rdf:type
?:url
?:urn
  • urn:nbn:de:0168-ssoar-239489 ()
?:volumeNumber
  • 39 (xsd:string)